The Pharmacy Budget Trap: SHARx Warns Discounts Alone Cannot Control Total Spending

Prescription drug utilization continues to reshape employer healthcare costs, particularly with the growing use of GLP-1s, specialty medications and other high-cost therapies. SHARx is encouraging employers to look beyond discounts and rebates and focus on the factors that truly drive total pharmacy spend, including utilization trends, treatment persistence and emerging therapies.

Effective pharmacy management requires more than negotiating a lower price. By improving visibility into utilization and identifying potential cost drivers earlier, employers can make more informed decisions around their pharmacy strategy while maintaining access to appropriate care.